160 related articles for article (PubMed ID: 11489827)
1. Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.
Ohta JI; Miyoshi Y; Uemura H; Fujinami K; Mikata K; Hosaka M; Tokita Y; Kubota Y
Clin Cancer Res; 2001 Aug; 7(8):2463-7. PubMed ID: 11489827
[TBL] [Abstract][Full Text] [Related]
2. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of erbB-2 gene amplification in bladder cancer.
Sauter G; Moch H; Moore D; Carroll P; Kerschmann R; Chew K; Mihatsch MJ; Gudat F; Waldman F
Cancer Res; 1993 May; 53(10 Suppl):2199-203. PubMed ID: 8097962
[TBL] [Abstract][Full Text] [Related]
5. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer.
Sauter G; Moch H; Gasser TC; Mihatsch MJ; Waldman FM
Cytometry; 1995 Sep; 21(1):40-6. PubMed ID: 8529469
[TBL] [Abstract][Full Text] [Related]
7. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
Krüger S; Weitsch G; Büttner H; Matthiensen A; Böhmer T; Marquardt T; Sayk F; Feller AC; Böhle A
Int J Oncol; 2002 Nov; 21(5):981-7. PubMed ID: 12370744
[TBL] [Abstract][Full Text] [Related]
9. [Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)].
Sauter G; Moch H; Gudat F; Mihatsch MJ; Haley J; Meecker T; Waldman F
Verh Dtsch Ges Pathol; 1993; 77():247-51. PubMed ID: 7511290
[TBL] [Abstract][Full Text] [Related]
10. Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization.
Aly MS; Khaled HM
Urol Oncol; 2004; 22(6):448-52. PubMed ID: 15610859
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization.
Ishikawa T; Kobayashi M; Mai M; Suzuki T; Ooi A
Am J Pathol; 1997 Sep; 151(3):761-8. PubMed ID: 9284825
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
13. C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?
Underwood M; Bartlett J; Reeves J; Gardiner DS; Scott R; Cooke T
Cancer Res; 1995 Jun; 55(11):2422-30. PubMed ID: 7757996
[TBL] [Abstract][Full Text] [Related]
14. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
[TBL] [Abstract][Full Text] [Related]
15. Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization.
Ooi A; Kobayashi M; Mai M; Nakanishi I
Lab Invest; 1998 Mar; 78(3):345-51. PubMed ID: 9520947
[TBL] [Abstract][Full Text] [Related]
16. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Coogan CL; Estrada CR; Kapur S; Bloom KJ
Urology; 2004 Apr; 63(4):786-90. PubMed ID: 15072912
[TBL] [Abstract][Full Text] [Related]
18. ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer.
Szöllösi J; Balázs M; Feuerstein BG; Benz CC; Waldman FM
Cancer Res; 1995 Nov; 55(22):5400-7. PubMed ID: 7585609
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
20. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.
Simon R; Richter J; Wagner U; Fijan A; Bruderer J; Schmid U; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Anabitarte M; Hering F; Hardmeier T; Schönenberger A; Flury R; Jäger P; Fehr JL; Schraml P; Moch H; Mihatsch MJ; Gasser T; Sauter G
Cancer Res; 2001 Jun; 61(11):4514-9. PubMed ID: 11389083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
